高盛：医疗CRO、CDMO反映美国《生物安全法》修订草案中条款的更新情景分析
中国银行·2024-05-28 05:42
更多资料加入知识星球：水木调研纪要关注公众号：水木纪要 Goldman Equity Sachs Research 27 May 2024 | 4:40PM HKT China Healthcare CRO/CDMO: Updated scenario analysis reflectino grandfather clause in revised draft of US BiOSECURE Act 开报数据 Updated scenario analysis on revised Biosecure Act: We continue to highlight that the bills are still in the legislative process, with some uncertainties around the final drafts, and we take no view on their final form or the likelihood of them becoming law. Following our prior analysis based on the pot ...